GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Initiator Pharma A/S INIT.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

2.40

+10.09%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in DKK, from our data supplier.

FY2025

Net income

−DKK 14.0m

FY2016FY2025

Free cash flow

−DKK 36.4m

FY2016FY2025

Shareholders' equity

DKK 29.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross profit−DKK 14.8m−DKK 11,073−DKK 15,443−DKK 25,338−DKK 14,265−DKK 6,134−DKK 5,518−DKK 7,545−DKK 5,396−DKK 693
Research and developmentDKK 4.2mDKK 1,778DKK 10,089DKK 17,375DKK 7,788DKK 3,426DKK 4,128DKK 5,716DKK 4,016—
Operating income−DKK 18.2mDKK 319,164DKK 2.4m−DKK 27.5mDKK 757,062−DKK 6,946−DKK 6,160−DKK 8,317−DKK 6,306−DKK 878
Net income−DKK 14.0m−DKK 12,932−DKK 15,087−DKK 25.4m−DKK 13.9m−DKK 5.7m−DKK 5.5m−DKK 6.8m−DKK 5.7m−DKK 588,365
Diluted earnings per share-0.20-0.00-0.00-0.61-0.32-0.21-0.21-0.36-0.50-0.05

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsDKK 33.0mDKK 15.3mDKK 19.6mDKK 31.9mDKK 35.4mDKK 10.3mDKK 7.5mDKK 11.4mDKK 6.1mDKK 371,356
Cash and short-term investmentsDKK 26.3mDKK 13.4mDKK 16.1mDKK 25.7mDKK 22.5mDKK 8.9mDKK 4.9mDKK 9.4mDKK 4.6mDKK 110,154
Total liabilitiesDKK 3.4mDKK 510,000DKK 12.3mDKK 9.4mDKK 12.3mDKK 787,565DKK 1.0mDKK 499,978DKK 2.2mDKK 616,068
DebtDKK 2.2m—DKK 10.2mDKK 8.3mDKK 8.8m—————
Shareholders' equityDKK 29.6mDKK 14.8mDKK 7.4mDKK 22.4mDKK 23.1mDKK 9.5mDKK 6.5mDKK 10.9mDKK 3.9m−DKK 244,712
Shares outstanding68m56m58m42m44m27m26m19m11m11m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−DKK 18.2m−DKK 12.1m−DKK 11.6m−DKK 21.6m−DKK 22.5m−DKK 5.3m−DKK 5.6m−DKK 9.0m−DKK 5.1m−DKK 117,409
Capital spending−DKK 18.2m———————−DKK 87,067−DKK 116,750
Free cash flow−DKK 36.4m−DKK 12.1m−DKK 11.6m−DKK 21.6m−DKK 22.5m−DKK 5.3m−DKK 5.6m−DKK 9.0m−DKK 5.2m−DKK 234,159

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Gross profit−DKK 8.5m−DKK 11.2m−DKK 6.2m−DKK 3.8m−DKK 2.7m−DKK 2.1m−DKK 1.3m−DKK 1.7m
Operating income−DKK 9.5m−DKK 11.4m−DKK 7.0m−DKK 4.3m−DKK 3.8m−DKK 2.7m−DKK 1.8m−DKK 2.1m
Net income−DKK 9.5m−DKK 11.3m−DKK 3.0m−DKK 4.3m−DKK 3.9m−DKK 2.7m−DKK 561,321−DKK 2.1m
Diluted earnings per share-0.14-0.17-0.04-0.06-0.06-0.04-0.01-0.04
Cash from operations−DKK 5.0m−DKK 11.0m−DKK 2.0m−DKK 4.0m——DKK 1.0m−DKK 1.0m
Capital spending——−DKK 2.0m—————
Free cash flow——−DKK 4.0m—————
Total assetsDKK 20.9mDKK 26.8mDKK 33.0mDKK 36.8mDKK 13.8mDKK 13.2mDKK 15.3mDKK 11.3m
Cash and short-term investmentsDKK 17.1mDKK 19.9mDKK 26.3mDKK 28.7mDKK 4.7mDKK 10.8mDKK 13.4mDKK 7.9m
DebtDKK 9.7mDKK 7.5mDKK 2.1mDKK 2.1mDKK 2.2m———
Shareholders' equityDKK 8.5mDKK 18.1mDKK 29.6mDKK 32.5mDKK 8.3mDKK 12.1mDKK 14.8mDKK 10.4m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-12.9%382.7%—
Net income-18.0%19.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-10.0-20538.4-24400.3-6.9-17.8-14.8-24.6-5.1-3.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.